価格表

在庫・価格 : 2024年04月27日 22時46分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
TumorTACS In Situ Apotosis Detection Kit (30 TESTS)
データシート※最新のデータシートでない場合があります
4815-30-K RSDアールアンドディー システムス
R&D Systems, Inc.
1 kit ¥104,000
(未発注)
追加

在庫・価格 : 2024年04月27日 22時46分 現在

TumorTACS In Situ Apotosis Detection Kit (30 TESTS)

  • 商品コード:4815-30-K
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥104,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Watanabe R et al. Ganglioside G(M3) overexpression induces apoptosis and reduces malignant potential in murine bladder cancer. Cancer Res. 2002 Jul;62(13):3850-4
Watanabe R et al
2002/01/01
Sample Type: Whole Cells PubMed
2 Singh RP et al. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft. Carcinogenesis 2007 Dec;28(12):2567-74
Singh RP et al
2007/01/01
Sample Type: Whole Tissue PubMed
3 Singh RP et al. Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis. Cancer Res. 2008 Mar;68(6):2043-50
Singh RP et al
2008/01/01
Sample Type: Whole Cells PubMed
4 Margulis V et al. Type III transforming growth factor-beta (TGF-beta) receptor mediates apoptosis in renal cell carcinoma independent of the canonical TGF-beta signaling pathway. Clin. Cancer Res. 2008 Sep;14(18):5722-30
Margulis V et al
2008/01/01
Sample Type: Whole Tissue PubMed
5 Scholz A et al. The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model. Gut 2009 Feb;58(2):261-70
Scholz A et al
2009/01/01
Sample Type: Whole Tissue PubMed
6 Chen TA et al. Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 production. PLoS ONE 2011;6(8):e23317
Chen TA et al
2011/01/01
Sample Type: Whole Tissue PubMed
7 Lin J et al. Nitidine chloride inhibits hepatic cancer growth via modulation of multiple signaling pathways. BMC Cancer 2014;14:729
Lin J et al
2014/01/01
Sample Type: tissue PubMed
8 Zhu K et al. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer. Oncol. Rep. 2014 Sep;32(3):1234-42
Zhu K et al
2014/01/01
Sample Type: tissue PubMed
9 Jain S et al. Preclinical pharmacologic evaluation of pralatrexate and romidepsin confirms potent synergy of the combination in a murine model of human T-cell lymphoma. Clin. Cancer Res. 2015 May;21(9):2096-106
Jain S et al
2015/01/01
Sample Type: Whole Tissue PubMed
10 Jain S et al. Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma. Blood 2015 Jul;126(3):354-62
Jain S et al
2015/01/01
Sample Type: Whole Tissue PubMed
11 Lee SJ et al. Distinct phospholipase C-β isozymes mediate lysophosphatidic acid receptor 1 effects on intestinal epithelial homeostasis and wound closure. Mol. Cell. Biol. 2013 May;33(10):2016-28
Lee SJ et al
2013/01/01
Application: TUNEL Assay, Sample Type: Whole Cells PubMed
12 Martin FL et al. Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012 Jan;302(2):R292-9
Martin FL et al
2012/01/01
PubMed
13 Barone TA et al. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma. Neuro-oncology 2017 02;19(2):186-196
Barone TA et al
2017/01/01
PubMed
14 Kalainayakan SP et al. Cyclopamine tartrate, a modulator of hedgehog signaling and mitochondrial respiration, effectively arrests lung tumor growth and progression. Sci Rep 2019 Feb;9(1):1405
Kalainayakan SP et al
2019/01/01
PubMed
15 Guha P et al. IPMK Mediates Activation of ULK Signaling and Transcriptional Regulation of Autophagy Linked to Liver Inflammation and Regeneration. Cell Rep 2019 Mar;26(10):2692-2703.e7
Guha P et al
2019/01/01
PubMed
16 Plyler ZE et al. Non-obstructive vas deferens and epididymis loss in cystic fibrosis rats. Mech. Dev. 2019 02;155:15-26
Plyler ZE et al
2019/01/01
PubMed
17 Hua Y et al. Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma. Clin. Cancer Res. 2013 Nov;19(22):6242-51
Hua Y et al
2013/01/01
PubMed
18 Liu Y et al. Rapamycin induces Bad phosphorylation in association with its resistance to human lung cancer cells. Mol. Cancer Ther. 2012 Jan;11(1):45-56
Liu Y et al
2012/01/01
PubMed
19 Ter-Avetisyan G et al. Bifurcation of axons from cranial sensory neurons is disabled in the absence of Npr2-induced cGMP signaling. J. Neurosci. 2014 Jan;34(3):737-47
Ter-Avetisyan G et al
2014/01/01
PubMed
20 Liu X et al. Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma. Cancers (Basel) 2019 Jul;11(7)
Liu X et al
2019/01/01
PubMed
21 Andreata F et al. Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model. Sci Rep 2020 07;10(1):11425
Andreata F et al
2020/01/01
PubMed
22 Tatsumi Y et al. Inhibition of Heparanase Expression Results in Suppression of Invasion, Migration and Adhesion Abilities of Bladder Cancer Cells. Int J Mol Sci 2020 May;21(11)
Tatsumi Y et al
2020/01/01
Species: Human PubMed
23 Nam SH et al. Tussilagone Reduces Tumorigenesis by Diminishing Inflammation in Experimental Colitis-Associated Colon Cancer. Biomedicines 2020 Apr;8(4)
Nam SH et al
2020/01/01
Species: Mouse PubMed
  • No.: 1
  • 文献情報:
    Watanabe R et al. Ganglioside G(M3) overexpression induces apoptosis and reduces malignant potential in murine bladder cancer. Cancer Res. 2002 Jul;62(13):3850-4
    Watanabe R et al
    2002/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Singh RP et al. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft. Carcinogenesis 2007 Dec;28(12):2567-74
    Singh RP et al
    2007/01/01
  • 備考:
    Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Singh RP et al. Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis. Cancer Res. 2008 Mar;68(6):2043-50
    Singh RP et al
    2008/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Margulis V et al. Type III transforming growth factor-beta (TGF-beta) receptor mediates apoptosis in renal cell carcinoma independent of the canonical TGF-beta signaling pathway. Clin. Cancer Res. 2008 Sep;14(18):5722-30
    Margulis V et al
    2008/01/01
  • 備考:
    Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Scholz A et al. The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model. Gut 2009 Feb;58(2):261-70
    Scholz A et al
    2009/01/01
  • 備考:
    Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Chen TA et al. Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 production. PLoS ONE 2011;6(8):e23317
    Chen TA et al
    2011/01/01
  • 備考:
    Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Lin J et al. Nitidine chloride inhibits hepatic cancer growth via modulation of multiple signaling pathways. BMC Cancer 2014;14:729
    Lin J et al
    2014/01/01
  • 備考:
    Sample Type: tissue
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Zhu K et al. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer. Oncol. Rep. 2014 Sep;32(3):1234-42
    Zhu K et al
    2014/01/01
  • 備考:
    Sample Type: tissue
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Jain S et al. Preclinical pharmacologic evaluation of pralatrexate and romidepsin confirms potent synergy of the combination in a murine model of human T-cell lymphoma. Clin. Cancer Res. 2015 May;21(9):2096-106
    Jain S et al
    2015/01/01
  • 備考:
    Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Jain S et al. Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma. Blood 2015 Jul;126(3):354-62
    Jain S et al
    2015/01/01
  • 備考:
    Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Lee SJ et al. Distinct phospholipase C-β isozymes mediate lysophosphatidic acid receptor 1 effects on intestinal epithelial homeostasis and wound closure. Mol. Cell. Biol. 2013 May;33(10):2016-28
    Lee SJ et al
    2013/01/01
  • 備考:
    Application: TUNEL Assay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Martin FL et al. Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012 Jan;302(2):R292-9
    Martin FL et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Barone TA et al. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma. Neuro-oncology 2017 02;19(2):186-196
    Barone TA et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Kalainayakan SP et al. Cyclopamine tartrate, a modulator of hedgehog signaling and mitochondrial respiration, effectively arrests lung tumor growth and progression. Sci Rep 2019 Feb;9(1):1405
    Kalainayakan SP et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Guha P et al. IPMK Mediates Activation of ULK Signaling and Transcriptional Regulation of Autophagy Linked to Liver Inflammation and Regeneration. Cell Rep 2019 Mar;26(10):2692-2703.e7
    Guha P et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Plyler ZE et al. Non-obstructive vas deferens and epididymis loss in cystic fibrosis rats. Mech. Dev. 2019 02;155:15-26
    Plyler ZE et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Hua Y et al. Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma. Clin. Cancer Res. 2013 Nov;19(22):6242-51
    Hua Y et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Liu Y et al. Rapamycin induces Bad phosphorylation in association with its resistance to human lung cancer cells. Mol. Cancer Ther. 2012 Jan;11(1):45-56
    Liu Y et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Ter-Avetisyan G et al. Bifurcation of axons from cranial sensory neurons is disabled in the absence of Npr2-induced cGMP signaling. J. Neurosci. 2014 Jan;34(3):737-47
    Ter-Avetisyan G et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Liu X et al. Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma. Cancers (Basel) 2019 Jul;11(7)
    Liu X et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Andreata F et al. Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model. Sci Rep 2020 07;10(1):11425
    Andreata F et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Tatsumi Y et al. Inhibition of Heparanase Expression Results in Suppression of Invasion, Migration and Adhesion Abilities of Bladder Cancer Cells. Int J Mol Sci 2020 May;21(11)
    Tatsumi Y et al
    2020/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Nam SH et al. Tussilagone Reduces Tumorigenesis by Diminishing Inflammation in Experimental Colitis-Associated Colon Cancer. Biomedicines 2020 Apr;8(4)
    Nam SH et al
    2020/01/01
  • 備考:
    Species: Mouse
  • 参照:
    PubMed